NewLimit
NewLimit is a biotechnology company working to extend human healthspan by developing epigenetic reprogramming therapies.
55 employees · est. 2022 · South San Francisco, United...
Relation
Discovering the relationships at the heart of biology to cure disease.
130 employees · est. 2019 · London, United Kingdom
Relation is the older company (2022 vs 2019).
2 signals in the last 90 days
Side-by-Side Comparison
| Metric | NewLimit | Relation |
|---|---|---|
| Founded | ||
| Founded | 2022 | 2019 older |
| Headquarters | ||
| Headquarters | South San Francisco, United States | London, United Kingdom |
| Employees | ||
| Employees | 55 | 130 |
| Industry | ||
| Industry | Biotechnology, Health Care | Biotechnology, Pharmaceutical |
| Funding Stage | ||
| Funding Stage | Series C | Unknown |
| Total Funding | ||
| Total Funding | $650.00M | $139.00M |
| Funding Rounds | ||
| Funding Rounds | 4 | 5 |
| Services | ||
| Services | Development of anti-aging medicines, Epigenetic reprogramming research, Genomic testing and analysis, AI-driven therapeutic design | Transformational Medicines Development, Disease Understanding, Target Selection, Drug Discovery, Interdisciplinary Collaboration |
| Target Customers | ||
| Target Customers | Biotechnology companies, Healthcare providers, Research institutions, Aging population | Biotech and Pharma Companies, Medical Researchers, Healthcare Professionals, Patients |
| Taxonomy | ||
| Taxonomy | Healthspan Extension, Epigenetic Reprogramming, Age-related Diseases, Regenerative Medicine, Functional Genomics, Therapeutic Development, Pooled Perturbation Screening, Machine Learning In Biotech, Epigenetics, Disease Biology, Genomic Research, Unmet Medical Needs, Cellular Regeneration | Transformational Medicines, Human Biology, Single-cell Analysis, Multi-omics, Drug Discovery, Clinical Insights, Genomics, Patient Tissue Analysis, Functional Assays, Human Genetics, Therapeutic Programs, Functional Genomics, Drug Target Selection |
| Website | ||
| Website | newlimit.com | relationrx.com |
About NewLimit
NewLimit is a promising player in the Biotechnology and Health Care industries, aiming to revolutionize human healthspan through cutting-edge epigenetic reprogramming therapies. Founded in 2022 and headquartered in the United States, the company focuses on treating age-related diseases by rejuvenati...
About Relation
Relation is an innovative player in the Biotechnology and Pharmaceutical sectors, based in the United Kingdom. Founded in 2019, this company is on the cutting edge of biotech, combining high-resolution biological insights with advanced machine learning techniques to pioneer new therapeutic solutions...
We will tell you when either one moves
BounceWatch watches NewLimit and Relation for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at NewLimit and Relation — by email.
Frequently Asked Questions
Compare NewLimit with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at NewLimit on 15 Jun 2026, and Relation on 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.